Advances in genomics and information technology are ushering in a new era for oncology drug development, but biopharmaceutical companies must move the conversation from cost to value.
May 24, 2016
The Art & Science of Evidence -- Oncology: Advancing cancer treatment in the age of precision medicine
“The Art & Science of Evidence – Oncology” is one in a series of compendiums featuring blogs and bylined articles from Quintiles’ experts.
Fresh ideas and insights from our experts around the globe